Matches in UGent Biblio for { <https://biblio.ugent.be/publication/1252093#aggregation> ?p ?o. }
Showing items 1 to 24 of
24
with 100 items per page.
- aggregation classification "V".
- aggregation creator person.
- aggregation date "2011".
- aggregation hasFormat 1252093.bibtex.
- aggregation hasFormat 1252093.csv.
- aggregation hasFormat 1252093.dc.
- aggregation hasFormat 1252093.didl.
- aggregation hasFormat 1252093.doc.
- aggregation hasFormat 1252093.json.
- aggregation hasFormat 1252093.mets.
- aggregation hasFormat 1252093.mods.
- aggregation hasFormat 1252093.rdf.
- aggregation hasFormat 1252093.ris.
- aggregation hasFormat 1252093.txt.
- aggregation hasFormat 1252093.xls.
- aggregation hasFormat 1252093.yaml.
- aggregation language "dut".
- aggregation subject "Business and Economics".
- aggregation title "Israëlische big farma doet overname van 6,8 miljard".
- aggregation abstract "The Israeli pharmaceutical company Teva has made another acquisition, after the German Ratiopharm (3,625 billion) and Corporacion Infarmasa (Peru), now Cephalon (USA) for 6,8 billion dollar. Medicines from TEVA are sold in Belgian pharmacies and covered by the national health insurance. Sales in 2010 total 16,1 billion dollar; net profit 3-4 billion. TEVA had several contracts with Flemish universities.".
- aggregation authorList BK52504.
- aggregation issue "4 mei".
- aggregation isDescribedBy 1252093.
- aggregation similarTo LU-1252093.